Skip to content

Green tea supplementation and dental care for neurological outcome in patients undergoing major abdominal surgery

Effect of green tea and dental care on postoperative delirium in adults undergoing major abdominal surgery: a randomized controlled trial (TEA-CARE Trial) - TEA-CARE Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/107099
Enrollment
544
Registered
2026-03-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K801- Calculus of gallbladder with othercholecystitis Health Condition 2: K311- Adult hypertrophic pyloric stenosis Health Condition 3: K742- Hepatic fibrosis with hepatic sclerosis

Interventions

Intervention1: Oral care group: Twice daily brushing for 2 minutes starting 5 days preoperatively Intervention2: Green tea group: Twice daily green tea intake 5 days preoperatively Intervention3: Comb

Sponsors

AIIMS, Bhubaneswar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient of ASA grade I-III, elective major abdominal surgery (intra-peritoneal operation with no primary involvement of the thorax involving either luminal resection and/or resection of solid organ associated with gastro intestinal tract for duration at least 2 hours, Planned for general anesthesia with or without regional anesthesia and expected postoperative stay more than 5 days

Exclusion criteria

Exclusion criteria: pre existing delirium or dementia, severe hepatic or renal dysfunction, chronic psychiatric illness or patient taking antipsychotic drugs, patient with alcohol dependence or substance abuse, patients with regular consumption of more than 800 mg of caffeine per day (equivalent to 8 to10 cups of coffee), allergy to green tea or dental products, patient with a potential for pregnancy, breastfeeding, or childbirth, have language, vision, or hearing impairments that may compromise cognitive assessments, patient on melatonin and dexamethasone more than 8mg, patients needing more than 24 hours elective mechanical ventilation will be excluded post-randomization

Design outcomes

Primary

MeasureTime frame
Incidence ofpostoperative deliriumTimepoint: first 48 hours after surgery

Secondary

MeasureTime frame
To compare severity of postoperative deliriumTimepoint: first 48 hours after surgery;To evaluate duration of mechanical ventilationTimepoint: first 48 hours after surgery;To evaluate the ICU & hospital length of stayTimepoint: ;To explore postoperative respiratory adverse eventsTimepoint: first 48 hours after surgery;Quality of recoveryTimepoint: at 24 hours;To compare CRP and procalcitoninTimepoint: baseline, 3rd and 5th postoperative days;To compare oral microbiological floraTimepoint: at baseline and after 5 postoperative days;To determine bowel recovery following surgeryTimepoint: ;To determine possible adverse effects (e.g., caffeine-related effects, gastrointestinal irritation, mouthwash sensitivities)Timepoint: first 48 hours after surgery

Countries

India

Contacts

Public ContactDevishree Das

All India Institute of Medical Sciences, Bhubaneswar

devishreedas111@gmail.com8895299296

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026